Follow the people · Insider

MH

Mark Hopman

Insider · Chief Commercial Officer · BBNX

Mark Hopman files insider transactions with the SEC as a chief commercial officer of Beta Bionics (BBNX). We hold 8 disclosed purchases and sales filed since 31 January 2025, 2 of them in the last 90 days.

  • Files forBBNX
  • Disclosed buys and sells8 in all, 2 in the last 90 days
  • Last disclosure3 September 2026

Positions held

1 post we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 29 January 20252 September 2026Chief Commercial Officer · Beta Bionics (BBNX)41 Form 4 lines · source: SEC Form 4

Everything they disclosed

41 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.